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Summary 
The ability to analyze T  cell receptor (TCR) thymic repertoire shaping in humans by self and 
foreign ligands is hampered by the lack of suitable models. We recently documented that the 
mouse severe combined immunodeficiency  (SCID)-human fetal liver/thymus model recapitulates 
the TCR Vfl gene repertoire of human thymocytes. Here, we show that an exogenous superantigen, 
staphylococcal enterotoxin  B,  administered  to  such  mice  induces  clonal  deletions  in  both 
CD4 +  8-  and CD8 +  4-  cells involving the same human V3 clones that are selected in vitro by 
this toxin. This model, therefore, may allow comprehensive studies into the effects of microbial 
and other agents on human T  cell thymic selection processes in a biologically relevant setting. 
S 
tudies in the mouse, have shown that the functional TCR 
repertoire is primarily shaped intrathymically by positive 
and negative selection processes  (for reviews see references 
1-3). In particular, negative selection imposed by mouse mam- 
mary tumor provirus (Mtv)-encoded endogenous superan- 
tigens causes the deletion of T cell clones expressing specific 
V3 genes (for reviews see references 4 and 5). Similarly, deple- 
tion of particular V3 T cell clones can be observed in mice 
(6) and rats (7) exposed to bacterial superantigens during the 
maturation of the TCR repertoire (for reviews see references 
8 and 9).  Through the use of transgenic mice, deletion of 
TCR-expressing cells recognizing conventional self-antigens 
has also been documented (3, 10). In humans, analysis of V3 
transcript levels in immature and mature thymocyte (11) and 
peripheral blood T cell subsets (12-15) have suggested posi- 
tive and negative selection, but definitive evidence for such 
processes is lacking. Moreover, although bacterial superan- 
tigens engage specific sets of human V3 clones in vitro (8 
and 9), their effects on in vivo thymic selection are unknown. 
To address thymic selection in humans in a setting amenable 
to  experimentation,  we  studied  TCR  V3  expression  in 
homozygous C.B-17 scid/scid mice reconstituted with human 
fetal liver and thymus (16-18).  It has been documented that 
in this model, human progenitor cells of fetal liver origin 
emigrate into the coimplanted fetal thymus and differentiate 
into immature double-positive CD4 +8 + and mature single- 
positive  CD4+8 -  and  CD8+4 -  T  cell  subsets  (17,  18). 
Using a  multiprobe RNase protection assay, we recently 
showed (19) that the TCR VB repertoire in the reconstituted 
thymus is virtually identical to the unselected repertoire in 
the thymus of the stem cell (liver) donor. Moreover, when 
identical stem cells developed in different thymic environments, 
significant differences in the V3 transcript levels of the selected 
mature T  cells were observed, indicating the influence of 
thymic genetic background-dependent polymorphic ligands 
in the selection process.  Here, we document that injection 
of a bacterial superantigen (staphylococcal enterotoxin B [SEB]) 
in such SCID-human fetal liver/thymus mice induces dele- 
tion of T cells expressing the same VB engaged by this toxin 
in vitro,  thereby establishing the use of this system in as- 
sessing the effects of microbial superantigens on the developing 
human immune system. 
Materiah  and Methods 
SCID-Human FetalLiver/T~mus Mice.  Human fetal livers and 
thymuses were obtained from donors between 15 and 21 wk gesta- 
tional age. Parts of the thymuses were kept for RNA preparation 
and the remainder used in the transplantation experiments. C.B-17 
scid/scid mice were transplanted under the kidney capsule  with small 
pieces of thymus and syngeneic or allogeneic liver, as described 
(16-18). 6 mo later, the thymuses were removed for analysis. 
Clonal Selection by SER  For studying SEB in vivo effects on 
the developing human TCR repertoire, eight SCID mice trans- 
planted 6 wk earlier with a syngeneic combination of human fetal 
liver and thymus were injected intraperitoneally with 12/~g SEB 
(Sigma Chemical Corp., St. Louis, MO) three times per week for 
4 wk. Thymuses were then removed from such animals, pooled, 
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sorting on a FACStar Plus  |  (Becton Dickinson & Co., Mountain 
View, CA) using FITC-conjugated anti-CD4 or PE-conjugated anti- 
CD8 antibodies ('Becton Dickinson & Co.). Control CD4"8-  and 
CD8"4-  thymocytes were similarly prepared from human  fetal 
liver/thymus  transplanted  mice not treated with SEB. 
For assessing in vitro V3 selection by SEB, PBLs (2.5  x  10  ~ 
per ml) from a normal adult donor were cultured in RPMI 1640 
medium containing  10% fetal calf serum, 5  x  10-2 mM 2-ME, 
2 mM g-glutamine, and SEB at a final concentration of 0.25 #g/ml. 
After 4 d at 37~  in 6% CO2, cultures were supplemented with 
20 U/ml recombinant human Ib2 (Genzyme Corp., Boston, MA), 
incubated  for an additional 48 h,  and harvested. 
RNase Protection Assay.  KNA isolation  from  the above cell 
preparations, riboprobe design and labeling and KNase protection 
assays, using 22 human V3 probes organized into three probe sets, 
were performed as we have recently described (11). Briefly, 2-3/zg 
of lyophilized total T cell KNA were hybridized with radiolabeled 
C3 probe  (103 cpm),  and with each of the probe sets (2  x  103 
cpm/uridine)  in 5 gtl hybridization buffer (80% formamide, 0.4 M 
NaC1, 1 mM EDTA, 40 mM Pipes, pH 6.7) at 56~  for 12-16 h. 
Unhybridized probes and target RNA were digested (1 h at 30~ 
with RNase A (5/~g/ml)  and T1 (10 U/ml) in 50 #1 of digestion 
buffer (10 mM Tris, pH 7.5, 5 mM EDTA, 0.3 M NaC1). Purified 
"protected" probe/RNA duplexes were electrophoresed in a stan- 
dard  6%  polyacrylamide  sequencing  gel,  and  autoradiography 
(10-20 h at  -70~  with intensifying screens) was performed on 
Kodak XR.P film. Quantitation  of VB transcript levels, was per- 
formed using a radioanalytic imaging apparatus (AMBIS; Ambis 
Systems, Inc., San Diego, CA). The net cpm at a given band corre- 
sponding to a specific protected VB probe was calculated by the 
formula: [(cpm of VB-specific  band)  -  (cpm background  around 
the band)]/(number of uridine residues in the specific V3 probe). 
This value was then expressed as percent of total C3 transcripts. 
Results and Discussion 
When thymus implants are engrafted alone into SCID mice, 
most (>90%) begin to atrophy (16),  and within 3 mo, are 
almost totally devoid of cortical thymocytes, in agreement 
with the long-standing notion that the self-renewing capacity 
of thymic stem cells is limited (20).  Continuous  human  T 
lymphopoiesis, however, occurs when a fragment of fetal liver, 
regardless of whether syngeneic or allogeneic,  is coimplanted 
with the fetal thymus into the SCID mouse (16-19).  To verify 
stability and completeness of thymic reconstitution  in  the 
set of mice used for the present study, total human thymo- 
cytes from control SCID mice implanted 6 mo earlier with 
human fetal tissues, were analyzed for VB gene expression. 
As depicted in Fig.  1, transcript  levels for the 22 V~ genes 
analyzed were similar in the transplanted human thymus and 
in  the  same  thymus  before implantation.  These  and  our 
previous results with  different sets of such mice (19) indi- 
cated that T cell reconstitution, encompassing precursors for 
the majority of clonotypes, reproducibly occurs in SCID- 
human  fetal liver/thymus  mice,  thereby strengthening  the 
use of this model in  the  study of human  T  ceU biology. 
In SCID mice reconstituted with allogeneic liver/thymus 
combinations, it has been shown, using mAbs against poly- 
morphic HLA detcHuinants, that the vast majority of thymo- 
Figure 1.  VB gene repertoire in SCID-human fetal liver/thymus  mice. 
Autoradiographic profiles  of VB gene expression  in a human fetal thymus 
before  (lanes I) and after (lanes  2) coimplantation with the syngeneic  fetal 
liver. Full-size  bands are identitied as specific  V3. Secondary  bands result 
from incompletely hybridized RNA cleaved into smaller fragments by 
RNase. 
cytes at  ,03 mo  after implantation  are of fetal  liver origin 
(16-18).  We have further  documented this by defining ex- 
pression patterns for a set of aUelic V3 genes (11, 21) distin- 
guishable by the RNase protection assay, wherein the allelic 
V~s present  in  the reconstituted  thymus were identical  to 
those in  the  genome of the liver donor  (19). 
Having clearly established that  the thymocytes and their 
V~ repertoires in SCID-human  fetal liver/thymus mice are 
similar to normal human fetal repertoires and are derived from 
liver progenitors,  we then addressed whether confrontation 
with a bacterial superantigen during development of the reper- 
toire leads to clonal deletions, as has been found in rodents 
(6, 7).  For this purpose, SCID mice coimplanted with syn- 
geneic human fetal thymus and liver were repeatedly injected 
intraperitoneally  with  staphylococcal enterotoxin  B  (SEB). 
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letions  by SEK Autoradiographic  profiles  with 
three Vfl gene  probe sets of thymocytes  from 
control (lanes 1  and 2  for CD4+8  -  and 
CD8+4 - cells, respectively)  and SEB-injected 
(lanes 3 and 4 for CD4+8  -  and CD8+4  - 
cells, respectively)  SCID-human fetal liver/ 
thymus mice.  Lane  5 depicts human  PBLs in- 
cubated in vitro with SEB. 
Injections were initiated 6 wk after implantation, when the 
number of cells already selected in the fetal  thymus trans- 
plant is very low, and continued thereafter three times per 
week for 4 wk during the emigration and intrathymic matu- 
ration of the liver progenitors. Total thymocytes were then 
isolated and sorted into CD4+8 -  and CD8+4 -  subsets,  and 
RNA from these single-positive populations was analyzed 
for VB transcript levels by the RNase protection assay. Con- 
trols included thymocytes from SCID mice reconstituted with 
human fetal liver/thymus but not injected with SEB and PBLs 
from an unrelated adult normal human donor stimulated in 
vitro with SEB. The autoradiographic profiles  are shown in 
Fig. 2, and the actual V~ transcript values are listed in Table 
1. In agreement with previous reports (5,  8, 9,  12), human 
PBLs cultured with SEB showed expansion of  cells expressing 
Vfl3, 12, 14, 15, 18 (alternatively V~/20) (12), and Vfi19 (al- 
ternatively Vfi17)  (12), but engagement of Vfl5.1, 5.2,  6.4, 
6.6,  and  17 (alternatively V~18)  (12) was also  noted (Fig. 
2, lane 5). SCID-human fetal liver/thymus mice injected with 
SEB (Fig.  2, lanes 3 and 4 for CD4§  -  and CD8+4 -  cells, 
respectively), compared with noninjected counterparts (Fig. 
2,  lanes 1  and 2  for CD4 +  8-  and CD8+4 -  cells,  respec- 
tively), remarkably showed a 50-90%  decline in transcript 
levels for the same V~s shown to be engaged in vitro by this 
toxin. Although the amount of TCR. mRNA, as evidenced 
by Cfl intensity, is lower in lanes  3  and 4 compared with 
lanes 1 and 2, the values given are calculated as percent C/~ 
in each lane and thus, are unbiased. Moreover, the SEB-induced 
deletions are selective, affect both low and highly expressed 
VBs  and,  conversely,  V/~s not  engaged  by  SEB  remain 
unaffected or compensatorily increased. Incomplete deletion 
for some SEB-selected donotypes may be due to lower affinity 
and/or to the presence of residual, already selected, single- 
positive cells in the human thymus that are resistant to dele- 
tion. Although, in some instances, the decline was more pro- 
nounced in the CD4+8 -  than the CD8+4 -  single-positive 
subset, both subsets  were affected. As documented in mice 
with both exogenous (6) and endogenous (22,  23) superan- 
tigens, as well as in mice expressing transgenic TCtL specific 
for a self-peptide (3, 10), it is likely that the clonal deletions 
had  occurred at  the immature  (double-positive)  stage  of 
differentiation. However, because class II MHC presented su- 
perantigens can bind VB without the participation of acces- 
sory coreceptors (for a review see reference 8), it is also pos- 
sible  that deletions affecting both  subsets may be induced 
at, or continue after, transition to the single-positive stage. 
These findings, together with our previous observation of 
clonal deletions and/or functional inactivation of  T cells reac- 
tive against alloantigens of fetal liver donors (18), dearly es- 
tablish that the SCID-human fetal liver/thymus model is fully 
functional in that it displays negative selection processes against 
both conventional antigens and superantigens. 
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in SCID-hu Fetal Liver/Thymus Mice with the In  Vitro 
SEB-engaged Human VI~ Clones 
SCID-human 
Control  SEB injected  PBL 
Vfl  CD4  CD8  CD4  CD8  Control  SEB 
1.1  0.89  1.54  0.27  0.62  0.92  1.01 
2.1  0.84  0.96  3.85  3.05  2.34  0.07 
3.1  1.63  1.70  0.20  0.83  2.27  11.83 
4.1  2.80  3.08  7.02  6.10  2.33  0.63 
5.1  6.49  3.90  2.59  1.66  4.38  6.01 
5.2  0.36  0.54  0.14  0.16  0.47  3.57 
6.4  1.10  1.80  0.46  0.57  1.85  2.47 
6.6  2.23  2.54  0.62  0.69  0.69  1.07 
7.1  0.94  2.35  3.03  4.18  1.14  0.27 
8.1  2.76  1.75  5.75  3.27  1.85  0.12 
8.2  1.20  1.11  1.61  2.44  1.09  0.06 
8.3  0.43  0.40  0.60  0.70  0.23  0.02 
11.1  1.74  1.75  1.31  1.60  0.37  0.30 
12.1  2.41  2.93  0.52  0.71  1.30  1.80 
13.1  3.53  3.43  4.74  5.27  1.53  0.36 
13.2  0.31  0.63  0.14  0.25  0.32  0.35 
14.1  1.83  2.94  0.53  0.45  2.43  10.19 
15.1  0.97  0.67  0.16  0.28  0.76  3.39 
16.1  0.23  0.16  0.61  0.37  0.24  0.05 
17.1  0.92  0.45  0.11  0.13  0.83  1.34 
18.1  1.77  0.98  0.15  0.14  1.02  4.05 
19.1  1.98  1.75  0.25  0.85  1.70  10.55 
Values represent vB transcript levels expressed as a percentage of total 
Cfl transcripts. 
Vfls selected by SEB are underlined. Transcript levels for Vfls engaged 
by this superantigen in vitro are higher than in control nonstimulated 
peripheral lymphocytes, whereas transcript levels for the same Vfls are 
lower in SEB-injected than noninjected SCID-human fetal liver/thymus 
mice, apparently because of clonal deletions. 
Clonal deletions in mice have also been shown to be con- 
ferred by molecules encoded by various mouse Mtv proviral 
integrants (4, 5) that might also affect the human VB reper- 
toire in the SCID-human fetal liver/thymus model. Such en- 
dogenous superantigens  of the normal BALB/c mouse (the 
background of the SCID mouse) delete  T  cells expressing 
Vfl3, 5, 11, and 12 (5, 8). Mouse Vfl3 is most homologous 
to human Vfll0 and 20, mouse Vfl5 is most homologous 
to human Vfll and 5, and mouse VB11 and 12 are most ho- 
mologous to human Vfl8 (24). Although Vfll0 and 20 were 
not included in our human Vfl probe sets, the V/31-, 5-, and 
8-expressing cells were not deleted in the single-positive subsets 
of the SEB nontreated SCID-human fetal liver/thymus mouse 
(Fig.  2, lanes I and 2). The most likely explanation for the 
absence of Mtv-mediated effects on the human repertoire is 
the  lack  of Mtv-presenting  B  cells  in  the  SCID  mouse. 
Nonetheless, because SCID mice transplanted with syngeneic 
fetal  thymus were  shown to  display  some of the BALB/ 
c-derived  endogenous superantigen-mediated VB deletions 
(20),  additional  mechanisms might be involved,  including 
Vfl structural differences between mouse and humans, and 
the inability of Mtv-encoded superantigens to be transferred 
to,  and presented by,  human APCs. 
The present study documents that: (a) the human Vfl reper- 
toire is fully displayed in SCID mice reconstituted with human 
fetal liver and thymus; (b) the human repertoire is unencum- 
bered by endogenous superantigen of the SCID mouse; and 
(c) clonal deletions can be manifested in the maturing human 
T  cell repertoire upon encounter  of an exogenous  superan- 
tigen. This is the first clear documentation of superantigen- 
induced clonal deletion in developing human T  cells. In view 
of the mounting evidence that microbial superantigens may 
play a role in  the pathogenesis  of several human disorders, 
including AIDS (25, 26), autoimmune diseases (27, 28) and 
toxic  shock  syndrome  (29),  the  use  of the  SCID-human 
liver/thymus model in assessing superantigenic and, in general, 
thymic repertoire-modifying effects of human pathogens in 
a  biologically relevant  setting  is evident. 
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